EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Can the Wondfo® SARS-CoV-2 IgM/IgG antibodies be used as a rapid diagnostic test?

Lysandro Pinto Borges, Makson Gleydson Brito De Oliveira, Daniela Raguer Valadão de Souza, Kezia Alves Dos Santos, Luana Heimfarth

Archives of Biotechnology and Biomedicine · 2020

DOI: 10.29328/journal.abb.1001017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biotechnology and Biomedicine, 2020. Verfasst von Lysandro Pinto Borges und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An outbreak of novel coronavirus (SARS-CoV-2) disease (COVID-19) has rapidly spread worldwide. The aim of this study was to evaluate and validate the performance of the Wondfo® lateral-flow immunochromatographic assay that detect SARS-CoV-2- IgG, IgM antibodies (Wondfo® IC), using the results obtained by the fluorescence immunoassay test as reference diagnostic. Material and methods: 97 serum specimens collected and analyzed by four independent laboratories of Sergipe/Brazil was used for validated the Wondfo® SARS-CoV-2 IgM/IgG antibodies test. The COVID-19 positive serum specimens were determined by fluorescence immunoassay technique, used as reference standard.

Results

An overall of 97 serum specimens show 39 (39/97) SARS-CoV-2 IgG positive specimens, 33 (33/97) SARS-CoV-2 IgM positive specimen and 25 non-reagent specimens (25/97). However, the Wondfo® IC assay detected only 9 (9/97) IgM/IgG positive specimen and 25 (25/97) no-reagent specimen. A weak correlation was found between the outcomes of the Wondfo® IC assay and fluorescence test. The accuracy between the two tests was 32.08%. The sensitivity, specificity, positive predictive value, and negative predictive value of Wondfo® IC assay were of 11.12%, 100%, 100% and 25.27%, respectively. Moreover, no false positive sample was determinate, whereas 88.89% of false negative results were found.

Conclusion

The Wondfo® IC test failed in providing a quick, valid, and reliable results and appears not to be a good alternative for clinical use in detecting pandemic coronavirus. However, if the limitations of the rapid test are known, some correction factors can be used in order to adjust the epidemiological data.

Zitieren

APA

Borges, L. P., Oliveira, M. G. B. D., Souza, D. R. V. D., Santos, K. A. D., & Heimfarth, L. (2020). Can the Wondfo® SARS-CoV-2 IgM/IgG antibodies be used as a rapid diagnostic test?. Archives of Biotechnology and Biomedicine. https://doi.org/10.29328/journal.abb.1001017

Vancouver

Borges LP, Oliveira MGBD, Souza DRVD, Santos KAD, Heimfarth L. Can the Wondfo® SARS-CoV-2 IgM/IgG antibodies be used as a rapid diagnostic test?. Archives of Biotechnology and Biomedicine. 2020. doi:10.29328/journal.abb.1001017

BibTeX
@article{Borges2020,
  author = {Borges, Lysandro Pinto and Oliveira, Makson Gleydson Brito De and Souza, Daniela Raguer Valadão de and Santos, Kezia Alves Dos and Heimfarth, Luana},
  title = {Can the Wondfo® SARS-CoV-2 IgM/IgG antibodies be used as a rapid diagnostic test?},
  journal = {Archives of Biotechnology and Biomedicine},
  year = {2020},
  doi = {10.29328/journal.abb.1001017}
}
Kostenlos starten →